Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Indutrade Q2 2025 - Organic headwinds persist, M&A likely to ramp in H2

Indutrade

Redeye updates its estimates and valuation after Indutrade’s Q2 2025 report. Larger-than-expected organic headwinds led to both top and bottom-line misses versus our projections. While we judge headline figures looked worse than underlying fundamentals suggest, Indutrade’s organic recovery proceeds more slowly than we pencilled in. Still, we believe the company will realise solid operating leverage once demand turns around.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Indutrade Q2 2025 - Organic headwinds persist, M&A likely to ramp in H2

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.